08.19.21
Adoptive transfer of tumor-infiltrating lymphocytes may be less effective in patients with metastatic melanoma
Patients with metastatic melanoma that had relapsed on anti-PD-1 therapies or BRAF/MEK inhibitors did not respond as well to an investigational therapy that involves the adoptive cell transfer of tumor-infiltrating lymphocytes (ACT-TIL) as patients naïve to these treatments, according to results of a study published in Clinical Cancer Research. Recent treatment options for patients with